McBee Brannin, Chief Development Officer at CoreWeave, Inc. (NASDAQ:CRWV), sold 53,000 shares of the company’s Class A Common Stock on July 13, 2026, for a total of $4,486,098. The shares were sold at prices ranging from $83.2654 to $88.2533 per share, as part of a pre-arranged Rule 10b5-1 trading plan adopted on March 5, 2026. Since the transaction, CoreWeave’s stock has declined to $77.14, down roughly 14% over the last week alone. The stock has fallen 46% over the past year and is now trading about 50% below its 52-week high of $153.20, according to InvestingPro data.
The sales followed the conversion of 52,500 shares of Class B Common Stock into Class A Common Stock on the same day. Each Class B share is convertible into one Class A share at the holder’s election or upon certain conditions, as detailed in the company’s organizational documents.
The transactions were conducted through several trusts. McBee Brannin, who serves as the sole trustee and beneficiary of the Canis Major 2025 GRAT, sold 40,000 shares of Class A Common Stock from this trust. The reporting person’s spouse, as the sole beneficiary and trustee of the Canis Minor 2025 GRAT, sold 12,500 shares of Class A Common Stock. An additional 500 shares of Class A Common Stock were sold from the Canis Major SM Trust, an irrevocable trust where McBee Brannin’s minor child is the beneficiary, and McBee Brannin holds the power to remove and replace the trustee.The insider sale comes as CoreWeave, valued at $43.61 billion, faces profitability challenges despite strong revenue growth of 130% over the last twelve months. For deeper insights into CoreWeave’s financial health and future prospects, investors can access the comprehensive Pro Research Report available on InvestingPro, which covers over 1,400 US equities with expert analysis and actionable intelligence.
Following these transactions, the Canis Major 2025 GRAT and the Canis Minor 2025 GRAT each hold 0 shares of Class A Common Stock. The Canis Major SM Trust holds 51,000 shares of Class A Common Stock, and 1,800 shares are held directly by the reporting person’s child.
Derivative holdings of Class B Common Stock remain across various entities. The Canis Major 2025 GRAT holds 3,677,227 shares, and the Canis Minor 2025 GRAT holds 486,205 shares. Other derivative holdings include 108,600 shares held by the Canis Major 2025 Family Trust LLC, 1,582,773 shares by the Canis Major 2026 GRAT, 122,000 shares by the Canis Minor 2025 Family Trust LLC, and 263,795 shares by the Canis Minor 2026 GRAT. McBee Brannin serves as manager for both the Canis Major 2025 Family Trust LLC and the Canis Minor 2025 Family Trust LLC.
In other recent news, Freedom Broker upgraded IREN Ltd. to a Buy rating from Hold, while maintaining a price target of $58.00. The firm has adjusted its revenue estimates for the upcoming quarters, projecting a more backend-weighted ramp in operations for the year. Meanwhile, CoreWeave has been the focus of several analyst reports, with Wolfe Research reiterating an Outperform rating and a $150 price target, despite increasing its fiscal 2026 capital expenditure estimate. Rosenblatt also maintained a Buy rating on CoreWeave with a $250 price target, following reports of Meta Platforms’ potential entry into the cloud business, which could impact CoreWeave’s market position. Evercore ISI echoed a similar sentiment, reiterating an Outperform rating and the same price target of $150. The Bloomberg report suggesting Meta’s plans to sell AI computing power and excess compute capacity has caused some movement in the market, with CoreWeave and Nebius Group shares experiencing a decline. These developments reflect ongoing strategic shifts and analyst evaluations in the tech sector.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
investment News
